Jonathan Thomson
CEO & Director
Good morning, everybody. Thanks for becoming a member of us. I am right here, as ordinary, with our CFO, Wilson Ng. I will say a couple of phrases on quarter 3, after which we’ll transfer as ordinary to Q&A. It has been one other nice quarter for us, 15% natural development, persevering with the momentum from the primary half of the 12 months. The sector traits are broadly the identical as they have been within the first half. Controls, very sturdy broad-based development, IS Group, Clarendon, Peerless, Windy nonetheless rising double digits, taking good market share in fast-growing finish markets. Life Sciences, conversely, markets are harder. We’re going via a little bit little bit of product cycle — product life cycle refresh. I am actually, actually happy with what we’re doing in Life Sciences, what the staff are doing, however we’ll count on low single-digit development for the 12 months.
Seals, we have seen some acceleration in quarter 3, and we’re anticipating quarter 4, too, not celebrating. Worldwide is a bit higher, however patchy and North American Seals continues to be doing very effectively. So look, general, we’re actually proud of the standard, with the efficiency of the portfolio. Peerless continues to carry out fantastically, taking share in actually good market circumstances. Development is moderating within the second half as we anticipated towards very large comps. And that may proceed to average into subsequent 12 months till we return to the monitor file of excessive
-1024x683.jpg?w=350&resize=350,250&ssl=1 "Liberty Lifestyle: The Death of Serendipity")
